3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Birken AG: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oleogel-S10 in Wound Healing of Inherited Epidermolysis Bullosa (BEB-10) Oleogel-S10, Mepilex® soft silicone faced polyurethane foam dressing - Inherited Epidermolysis Bullosa | Phase 2 | Completed | Birken AG | 10 | 2010-11-01 | 2018-01-23 |
| Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 Versus Moist Wound Healing Dressing Alone in Accelerating the Epithelialization of Split Thickness Skin Graft Donor Sites Oleogel-S10, Moist wound healing dressings alone (Mepilex) on the other half of the skin graft donor site - Accelerating the Epithelialization of Split Thickness Skin Graft | Phase 2 | Completed | Birken AG | 24 | 2010-04-01 | 2015-04-03 |
| The Efficacy and Tolerability of Oleogel-S-10 in Patients With Actinic Keratoses Oleogel-S10 100 mg/g, Placebo (petroleum jelly) - Actinic Keratoses | Phase 2 | Completed | Birken AG | 165 | 2008-10-01 | 2015-09-14 |
Epidermolysis Bullosa (1) · Keratosis, Actinic (1)
Petrolatum (1) · Transdermal Patch (1)
Germany (3) · Greece (1)
Agnes Schwieger-Briel, MD (1) · Claus Garbe, Prof. Dr. (1) · Hans Robert Metelmann, Prof. Dr. med. (1)